Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 950 of 2228 entries
View as:

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306

Phase: N/A Priority: Normal
NCT ID: NCT01611311 Org: User:
Start: 05/01/12 End: 08/01/12 Due: 08/01/13

Drug-interaction Trial in Healthy Subjects With Oral Administration of Empagliflozin (BI 10773), Rifampicin and Probenecid

Phase: N/A Priority: Normal
NCT ID: NCT01634100 Org: User:
Start: 06/30/12 End: 08/31/12 Due: 08/31/13

Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02044367 Org: User:
Start: 01/31/14 End: 04/30/14 Due: 04/30/15

Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02233894 Org: User:
Start: 02/28/01 End: - Due: -

BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00796549 Org: User:
Start: 12/31/08 End: - Due: -

Relative Bioavailability of BI 44847 in Different Ethnic Groups and Evaluation of Effect of Diet and Acarbose Coadministration on Bioavailability Following Oral Administration of 200 mg BI 44847 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02211950 Org: User:
Start: 10/31/08 End: - Due: -

Alteplase Treatment in Elderly Acute Ischaemic Stroke (AIS) Patients

Phase: N/A Priority: Normal
NCT ID: NCT05401149 Org: User:
Start: 07/18/22 End: 12/14/22 Due: 12/14/23

Patient Convenience Study- NIS RELATE

Phase: N/A Priority: Normal
NCT ID: NCT02849509 Org: User:
Start: 06/20/16 End: 12/30/17 Due: 12/30/18

Postmarketing Surveillance Study of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease

Phase: N/A Priority: Normal
NCT ID: NCT02244216 Org: User:
Start: 04/30/00 End: - Due: -

Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT05022784 Org: User:
Start: 08/23/21 End: 12/30/21 Due: 12/30/22

Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02238275 Org: User:
Start: 06/30/02 End: - Due: -

A Study to Test How Well Different Doses of BI 1356225 Are Tolerated by Men and Women With Obesity or Overweight

Phase: N/A Priority: Normal
NCT ID: NCT04447261 Org: User:
Start: 06/30/20 End: 04/25/21 Due: 04/25/22

Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)

Phase: N/A Priority: Normal
NCT ID: NCT00776984 Org: User:
Start: 10/31/08 End: - Due: -

Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02218671 Org: User:
Start: 03/31/00 End: - Due: -

Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00730821 Org: User:
Start: 01/31/07 End: - Due: -

Tiotropium (Spiriva) Rehabilitation Study

Phase: N/A Priority: Normal
NCT ID: NCT00274521 Org: User:
Start: 05/31/01 End: - Due: -

to Evaluate Effect of Multi Doses Flibans 100 mg Film-c Tablets on Single Dose PK of Digoxin 0.5 mg, Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01134965 Org: User:
Start: 06/30/10 End: - Due: -

Bioavailability Study of Five Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02710630 Org: User:
Start: 03/22/16 End: 06/10/16 Due: 06/10/17

Bioavailability of Dabigatran With or Without Clarithromycin in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171585 Org: User:
Start: 06/30/08 End: - Due: -

Efficacy and Tolerability of a Bilberry Extract in Volunteers With Impaired Twilight and Night Vision

Phase: N/A Priority: Normal
NCT ID: NCT02194127 Org: User:
Start: 11/30/98 End: - Due: -

BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00727506 Org: User:
Start: 07/14/08 End: 05/25/16 Due: 05/25/17

Investigation of Food Effect and Gastric ph Increase on the Bioavailability of Faldapravir

Phase: N/A Priority: Normal
NCT ID: NCT01694706 Org: User:
Start: 09/30/12 End: 12/31/12 Due: 12/31/13

SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC

Phase: N/A Priority: Normal
NCT ID: NCT00440271 Org: User:
Start: 02/28/07 End: - Due: -

Specific Use-Result of Spiriva Respimat® in Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT03188120 Org: User:
Start: 07/04/17 End: 11/08/18 Due: 11/08/19

Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT02732951 Org: User:
Start: 04/14/16 End: 10/24/17 Due: 10/24/18